Perimenstrual symptoms and syndromes: Guidelines for symptom management and self care

Advanced Studies in Medicine

Volumn 5, Issue 5, 2005, Pages 228-241

  Taylor, Diana ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; MEDROXYPROGESTERONE; PAROXETINE; PROGESTERONE;

ANXIETY; BEHAVIOR THERAPY; CHRONIC DISEASE; CLINICAL FEATURE; COGNITIVE THERAPY; DYSPHORIA; EMOTIONAL STRESS; EVIDENCE BASED MEDICINE; EXERCISE; HUMAN; IRRITABILITY; MENSTRUAL CYCLE; MENTAL INSTABILITY; MOOD DISORDER; PELVIS PAIN SYNDROME; PHOTOTHERAPY; PRACTICE GUIDELINE; PREMENSTRUAL SYNDROME; REVIEW; SCREENING; SELF CARE; SOCIOLOGY;

EID: 19544390320     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Dewees WP. A Treotise on the Diseoses of Femoles. 8th ed. Philadelphia, Pa: Lea & Blanchard; 1843.
2. Taylor D. "It's all in your head" to "Taking back the month": contributions to understanding PMS from the Society for Menstrual Cycle Research. Proceedings of the Meeting or the Society for Menstrual Cycle Research, Pittsburgh, Pa, June 2003. In press.
3. Association of Women's Health, Obstetric & Neonatal Nurses (AWHONN). Evidence-Based Clinical Practice Guideline: Nursing Management for Cyclic Perimenstrual Pain and Discomfort. Washington, DC: Association of Women's Health, Obstetric & Neonatal Nurses; 2003.
4. Collins Sharp BA, Taylor DL, Thomas KK, Killeen MB, Dawood MY. Cyclic perimenstrual pain and discomfort: the scientific basis for practice. J Obstet Gynecol Neonatal Nurs. 2002;31:637-649.
5. Woods NF, Most A, Dery G. Estimating the prevalence of perimenstrual symptoms. Am j Public Health. 1982;72:1257-1264
6. American Psychiatric Association. Diagnostic and Statistical Manual. 3rd ed. Washington, DC: American Psychiatric Press Inc; 1987.
7. Taylor D. Evaluating therapeutic change in symptom severity at the level of the individual woman experiencing severe PMS Image J Nurs Sch. 1994;26:25-33.
8. American Psychiatric Association. Diagnostic and Statistical Manual. 4th ed. Washington, DC: American Psychiatric Press Inc; 1994.
9. Angst J, Sellaro R, Merikangas K, Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand. 2001;104:110-116.
10. Woods NF, Dery GK, Most A. Stressful life events and perimenstrual symptoms. j Hum Stress 1982;8:23-31.
11. Ross LE, Steiner M. A biopsychosocial approach to premenstrual dysphoric disorder. Psychiatr Clin North Am. 2003;26:529-546.
12. Moynihan R. Controversial disease dropped from Prozac product information. BMJ. 2004;328:365.
13. Woods NF, Mitchell ES, Lentz M. Premenstrual symptoms: delineating symptom clusters. J Womens Health Gend Based Med. 1999;8:1053-1062.
14. Taylor D, Colino S. Taking Back the Month: A Personalized Solution to Managing PMS and Enhancing Your Health. New York, NY: Perigee/Putnam-Penguin; 2002.
15. Harrison MM, Ahlgrimm M. Self-help for premenstrual syndrome. 3rd ed. New York: Random House; 1998.
16. World Health Organization Task Force on Psychosacial Research in Family Planning, Special Program of Research, Development and Research, Training in Human Reproduction. A cross-cultural study of menstruation: implications for contraceptive development and use. Stud Fam Plann. 1981;12:3-16.
17. Woods NF. Premenstrual symptoms: another look. Public Health Rep. Jul-Aug: 1987;106-112.
18. Woods NF, Taylor D, Mitchell ES, Lentz MJ. Premenstrual symptoms and health-seeking behavior. West J Nurs Res. 1992;14:418-439.
19. Hourani LL, Yuan H, Bray RM. Psychosocial and lifestyle correlates of premenstrual symptoms among military women. J Women's Health. 2004;13:812-821.
20. Moos R. Typology of menstrual cycle symptoms. Am J Obstet Gynecol. 1969;103:390-402.
21. Taylor D Development of perimenstrual symptom typologies. Commun Nurs Res. 1986;19:168.
22. Dawood MY. Dysmenorrhea and prostoglandins: pharmacological and therapeutic considerations. Drugs. 1981;122:42-56.
23. Dawood MY. Dysmenorrhea. Clin Obstet Gynecol. 1990;33:168-178.
24. Chan WY, Dawood MY Prostaglandin levels in menstrual fluid of nondysmenorrheic and or dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy. Adv Prostoglandin Thromboxone Res. 1980;8:1443-1447.
25. Smith R. Cyclic pelvic pain and dysmenorrhea. Obstet Gynecol Clin North Am. 1993;20:753-764.
26. American College of Obstetricians & Gynecologists. ACOG Practice Bulletin (No 51): Chronic Pelvic Pain. Washington, DC: American College of Obstetricians & Gynecologists; 2004.
27. Backstrom T, Sanders G, Leask R, Davidson D, Warner P, Bancroft J. Mood, sexuality, hormones, and the menstrual cycle: II. Hormone levels and their relationship to premenstrual syndrome. Psychosom Med. 1983;45:503-507.
28. Keye WR jr. The biomedical model of premenstrual syndrome: past, present and future. In: Voda A, Conover R, eds. Proceedings of the 8th Conference of the Society far Menstrual Cycle Research. Salt Lake City, Utah: Society for Menstrual Cycle Research; 1989:589-600.
29. O'Brien PMS. Controversies in premenstrual syndrome: etiology and treatment. In. Ginsburg BE, Carter BF, eds. Premenstrual Syndrome: Ethical and Legal Implications in a Biomedical Perspective. New York, NY: Plenum; 1987:3177-3328.
30. Reid RL, Yen SSC. Premenstrual syndrome. Am J Obstet Gynecol. 1981;139:85.
31. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry. 1998;44:839-850.
32. Freeman EW. Premenstrual syndrome: current perspective an treatment and etiology. Curr Opin Obstet Gynecol. 1997;9:147-153.
33. Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand. 2001;104:110-116.
34. Halbreich U. Menstrually related disorders - towards interdisciplinary international diagnostic criteria. Cephalalgia. 1997;17:1-4.
35. Halbreich U. Premenstrual syndromes: Closing the 20th century chapters. Current Opin Obstet Gynecol. 1999;9:147-153.
36. Kendler KS, Karkowski LM, Corey LA, Neole MC. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms ond lifetime major depression. Am J Psychiatry. 1998;155:1234-1240.
37. Rubinow DR, Schmidt PJ. The neuroendocrinology of menstrual cycle mood disorders. Ann N Y Acad Sci. 1995;771:648-659.
38. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med, 1998;338:209-216.
39. Taylor D, Woods N, Lentz M, Mitchell E, Lee K. Premenstrual negative affect: development and testing of an explanatory model. In: Taylor D, Woods N, eds. Menstruation, Health and Illness. New York, NY: Hemisphere: 1991.
40. Cahill CA. Differences in cortisol, a stress hormone, in women with turmoil-type premenstrual symptoms. Nurs Res. 1998;47:278-284.
41. Lewis LL, Greenblatt EM, Rittenhouse CA, Veldhuis JD, Jaffe RB Pulsatile release patterns of luteinizing hormone and progesterone in relation to symptom onset in women with premenstrual syndrome. Fertil Steril. 1995;64:288-292.
42. Reame N, Kelch R, Beitins I, Yu M, Zawacki C, Padmanabhan V. Age effects of FSH and pulsatile LH secretion across the menstrual cycle of premenopausal women J Clin Endocrinol Metab. 1996;81:1512-1518.
43. Reame N, Marshall J, Kelch R. Pulsatile LH secretion in women with premenstrual syndrome (PMS): evidence for normal neuroregulation of the menstrual cycle. Psychoneuroendocrinology. 1992;17:205-213.
44. Ross L, Sellers E, Gilbert-Evans S, Romach M. Mood changes during pregnancy and the postpartum period: development of a biopsychosocial model. Acta Psychiatr Scand. 2004;109:457-466.
45. Taylor D. Stress & perimenstrual negative affect: hormonal & behavioral dimensions [abstract]. In: Abstracts of the 9th Conference of the Society for Menstrual Cycle Research. Seattle, Wash: Society for Menstrual Cycle Research; 1991:55.
46. Thys-Jacobs S. Micronutrients and the premenstrual syndrome: the case for calcium. J Am Coll Nutr. 2000;19:220-227.
47. Ussher JM. Processes of appraisal and coping in the development and maintenance of premenstrual dysphoric disorder. J Community Appl Soc Psychol. 2002;12:309-322.
48. Bloch M, Schmidt P, Su T, Tobin M, Rubinow D. Pituitoryadrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls. Biol Psychiatry. 1998;43:897-903.
49. Rubinow DR, Schmidt PJ, Roca CA. Hormone measures in reproductive endocrine-related mood disorders: diagnostic issues. Psychopharmacol Bull. 1998;34:289-290.
50. Ross L. Rethinking mentol health and disorder: feminist perspectives Arch Women Ment Health 2004;7:151-152.
51. Praschak-Rieder N, Willeit M, Winkler D, et al. Role of family history and 5-HTTLPR polymorphism in female seasonal affective disorder patients with and without premenstrual dysphoric disorder. Eur Neuropsychopharmocol. 2002;12:129-34.
52. Gallant SJ. The role of psychological factors in the experience of premenstrual symptoms. In: Proceedings of the 9th Conference of the Society for Menstrual Cycle Research. Seattle, Wash: Society for Menstrual Cycle Research; 1991.
53. Woods NF, Lentz M, Mitchell ES, Heitkemper M, Shaver J, Henker R. Perceived stress, physiologic stress orousal and premenstrual symptoms: group differences and intra-individual patterns. Res Nurs Health. 1998;21:511-523.
54. Freeman E, Sondheimer S, Rickels K. Effects of medical history factors on symptom severity in women meeting criteria for premenstrual syndrome. Obstet Gynecol. 1988;72:236-239.
55. Gise L, Lebovits A, Paddison PL, Strain JJ. issues in the identification of premenstrual syndromes. J Nerv Ment Dis. 1990;178:228-234.
56. Taylor D. The perimenstrual symptom management program: Elements of effective treatment [Capsules & Comments] Perinat Womens Health Nurs. 1996;2:140-151.
57. Golding JM, Taylor DL, Menard L, King MJ. Prevalence of sexual abuse history in a sample of women seeking treatment for premenstrual syndrome. J Psychosom Obstet Gynoecol. 2000;21:69-80.
58. Baco-Garcio E, Diaz-Sostre C, Severino A, et ol. Premenstrual symptoms ond luteol suicide attempts. Eur Arch Psychiatry Clin. 2004;254:326-329.
59. Janiger O, Riffenburgh M, Kersh M. A cross-cultural study of premenstrual symptoms. Psychosomatics. 1972;13:226-235.
60. Futterman LA, Jones JE, Miccio-Fonseca LC, Quigley ME. Severity of premenstrual symptoms in relation to medical/psychiatric problems and life experiences. Percept Mot Skills. 1992;74:787-799.
61. Huerta-Franco MR, Malacara JM. Association of physical and emotional symptoms with the menstrual cycle and lifestyle. J Reprod Med, 1993;38:448-454.
62. Marvan ML, Diaz-Erosa M, Montesinos A. Premenstrual symptoms in Mexican women with different educational levels. J Psychol. 1998;132:517-526.
63. Taylor D. Effectiveness of professional-peer group treatment: symptom management for women with PMS. Res Nurs Health. 1999;22:496-511.
64. Taylor D. More than personal change: effective elements of symptom management. Nurse Pract Forum. 2000;11:79-86.
65. Mitchell ES. Identification of recurrent symptom severity patterns across multiple menstrual cycles. In: Proceedings of the 9th Conference of the Society for Menstrual Cycle Research. Seattle, Wash: Society for Menstrual Cycle Research: 1991:73-82.
66. Shaver JF, Woods NF. Concordance of perimenstrual symptoms across two cycles. Res Nurs Health. 1985;8:313-319.
67. Mitchell E, Woods N, Lentz M, Toylor D. Recognizing PMS when you see it: criteria for PMS sample selection. In: Taylor DL, Woods NF, eds. Menstruation, Health and Illness. New York, NY: Hemisphere: 1991:89-102.
68. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin (No 15): Management of Premenstrual Syndrome. Washington, DC: American College of Obstetricians and Gynecologists: 2000.
69. Woods NF, Lent M, Mitchell ES, Heitkemper M, Shaver J. PMS after 40: persistence of o stress-reloted symptom pattern. Res Nurs Health. 1997;20:329-340.
70. Frank R. The hormonal causes of premenstrual tension. Arch Neurol Psychiatry. 1931;26:1031-1033.
71. Severino SK, Moline ML. Premenstrual syndrome: identification and management. Drugs. 1995;49:71-82.
72. Keye W. The Premenstrual Syndrome. Philadelphia, Pa: WB Saunders: 1988.
73. Taylor D. Nursing Interventions for Premenstrual Syndrome: A Longitudinal Therapeutic Trial. Seattle, Wash: University of Washington: 1988.
74. Dodd M, Janson S, Facione N, et al. Advancing the science of symptom management. J Adv Nurs. 2001;33:668-676.
75. The University of California, San Francisco School of Nursing Symptom Management Faculty Group. A model for symptom management, Imoge J Nurs Sch. 1994;26:272-276.
76. Beck A, Scott J, Williams P, et al. A randomized trial of group outpatient visits for chronically ill older HMO members: the Cooperative HealthCare Clinic. J Am Geriatr Soc. 1997;45:543-549.
77. Hegyvary S. Patient care outcomes related to management of symptoms. Ann Rev Nurs Res. 1993;11:145-168.
78. Robertson M. A survey of multidisciplinary and interdisciplinary approaches to premenstrual syndrome. In: Taylor DL, Woods NF, eds Menstruation, Health and Illness. New York, NY: Hemisphere: 1991:129-142.
79. Dimmock P, Wyatt K, Jones P, O'Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet. 2000;356:1131-1136.
80. Steiner M, Korzekwa M, Lamont J, Wilkins A. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol Bull. 1997;33:771-774.
81. Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med. 1995;332:1529-1534.
82. Agency for Healthcare Research and Quality. Depression. National Guideline Clearinghouse, from www.guideline.gov. Research. 2002:139-152.
83. Brigham and Women's Hospital. Depression: A Guide to Diagnosis ond Treatment Boston, Moss: Brigham ond Women's Hospital: 2001.
84. Luisi AF, Powosouskos JE. Treotment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors. Pharmacotherapy. 2003;23:1131-1140.
85. Yankers K, Halbreich U, Freeman E, Brown C, Endicott J, Frank E. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. JAMA. 1997;278:983-988.
86. Freeman E, Rickels K, Sondheimer S, Polansky M. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA. 1995;274:51-57.
87. Casson P, Hahn P, Van Vugt D, Reid R. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol. 1990;162:99-105.
88. Freeman E, Rickels K, Sondheimer SJ, Polansky M. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. JAMA. 1990;264:349-353.
89. Freeman E, Sondheimer S, Rickels K. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull. 1997;33:303-309.
90. Phillis JW. Steroids and brain cell activity during the menstrual cycle. In: Taylor D, Woods NF, eds. Menstruation, Health and Illness. Washington, DC: Hemisphere; 1991:49-58
91. Wyatt K, Dimmock P, Jones P, Obhrai M, O'Brien S. Efficacy of progesterone ond progestogens in management of premenstruol syndrome: systematic review. BMJ. 2001;323:776-780.
92. Mortorono J, Ahlgrimm M, Colbert T. Differentiating between natural progesterone ond synthetic progestins: clinical implications for premenstrual syndrome and perimenopause management. Compr Ther. 1998;24:336-339.
93. Prior J, Hitchcock C, Kingwell E, Vigno Y, Bishop C, Pride S. Perimenopausal bone loss: more than estrogen depletion. J Bone Miner Res 2001;16:2365-2366.
94. Kirkby RJ. Changes in premenstrual symptoms and irrationol thinking following cognitive-behavioral coping skills training. J Consult Clin Psychol. 1994,62:1026-1032.
95. Van Zok D. Biofeedback treatments for premenstrual and premenstrual effective syndromes. Int J Psychosom. 1984;41:53-60.
96. Barnard ND, Sciolli AR, Bertron P, Hurlock D, Edmonds K, Talev L. Effectiveness of low-fat vegetarian diet in altering serum lipids in healthy premenopausal women. Am J Cardiol. 2000;85:969-972.
97. Sayegh R, Schiff I, Wurtman J, Spiers P, McDermott J, Wurtman R. The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol. 1995;86(4, pt 1):520-528.
98. Rossignol AM, Bonnlander H. Coffeine-containing beverages, total fluid consumption, and premenstrual syndrome. Am J Public Health. 1990;80:1106-1110.
99. Ussher JM, Swann C. A double blind placebo controlled triol examining the relationship between health-related quality of life and dietary supplements. Br J Health Psychol. 2000;5 (pt 2)173-187.
100. Stevinson C, Ernst E. Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials. Am J Obstet Gynecol. 2001;185:227-235.
101. Girman A, Lee R, Kligler B. An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol. 2003;188:S56-S65.
102. Abraham G, Hargrove J. Effect of vitamin B6 on premenstrual symptomology in women with premenstrual tension syndrome: A double-blind crossover study. Infertility. 1980;3:155.
103. De Souza MC, Walker AF, Robinson PA, Bolland K. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med. 2000;9:131-139.
104. Doll H, Brown S, Thurston A, Vessey M. Pyridoxine and the premenstrual syndrome: A randomized crossover trial J R Coll Gen Pract. 1989;9:364-368.
105. Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol. 1996;174:1335-1338.
106. Thys-Jacobs S, Ceccarelli S, Bierman A, Weisman H, Cohen MA, Alvir J. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med. 1989;4:183-189.
107. Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol. 1998;179:444-452.
108. Douglas S. Premenstrual syndrome: evidence-based treatment in family practice. Can Fam Physician. 2002;48: 1789-1797.
109. Miller MN, McGowen KR, Miller BE, Coyle BR, Hamdy R. Lessons learned about research on premenstrual syndrome. J Womens Health Gend Based Med. 1999;8:989-993.
110. Prior J, Vigna Y, Alojada N. Conditioning exercise decreases premenstrual symptoms: a prospective controlled three month trial. Eur J Appl Physiol Occup Physiol. 1986;55:349-355.
111. Goodale IL, Domar AD, Benson H. Alleviation of premenstrual syndrome symptoms with the relaxation response. Obstet Gynecol. 1990;75:649-655.
112. Hunter MS, Ussher JM, Browne SJ, Coriss M, Jelley R, Kotz M. A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder. J Psychosom Obstet Gynaecol. 2002;23:193-199.
113. Brown M, Zimmer P. Personal and family impoct of premenstrual symptoms. J Obstet Gynecol Neonatal Nurs. 1986;15:31-38.
114. Ornitz AW, Brown MA. Family coping and premenstrual symptomatolagy. J Obstet Gynecol Neonatal Nurs. 1993;22:49-55.
115. Rittenhouse CA. The emergence of premenstrual syndrome as a social problem [abstract]. In: Abstracts of the 9th Conference of the Society for Menstrual Cycle Research. Seattle, Wash: Society for Menstrual Cycle Research; 1993:31.
116. Winter EJ, Ashton DJ, Moore DL Dispelling myths: a study of PMS and relationship satisfaction. Nurse Pract. 1991;16:34,37-40,45.
117. Sveinsdottir H, Morteinsdottir G. Retraspective assessment af premenstrual changes in Icelandic women. Health Care Women Int. 1991;12:303-315.
118. Morse G. Positively reframing perceptions of the menstrual cycle among women with premenstrual syndrome. J Obstet Gynecol Neonatal Nurs. 1999;28:165-174.
119. Taylor D, Bledsoe L. PMS, stress and social support: o pilot study and therapeutic hypothesis. In: Oleson V, Woods N, eds. Culture, Society, and Menstruation. Washington, DC: Hemisphere; 1985.
120. Alonso C, Coe CL. Disruptions of social relationships accentuate the association between emotional distress and menstrual pain in young women Health Psychol. 2001;20:411-416.
121. Lam RW, Carter D, Misri S, Kuan AJ, Yatham LN, Zis AP. A controlled study of light therapy in women with late luteal phase dysphoric disorder. Psychiatry Res. 1999;86:185-192.
122. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomized, placebo controlled study BMJ. 2001;322:134-137.
123. Loch E, Selle H, Boblitz N. Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Womens Health Gender-Based Med. 2000;9:315-320.